• Exchange: NASDAQ GS
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Biotech

AMAG Pharmaceuticals Inc

+ Add to Watchlist

AMAG:US

17.9400 USD 0.5000 2.71%

As of 20:10:00 ET on 07/28/2014.

Snapshot for AMAG Pharmaceuticals Inc (AMAG)

Open: 18.4200 Day's Range: 17.8200 - 18.5700 Volume: 286,760
Previous Close: 18.4400 52wk Range: 16.4900 - 28.4172 1-Yr Rtn: -16.56%

Stock Chart for AMAG

No chart data available.
  • AMAG:US 17.9550
  • 1D
  • 1M
  • 1Y
18.4400
Interactive AMAG Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for AMAG

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) -
Relative P/E vs. SPX -
Earnings Per Share (USD) (ttm) -0.3611
Est. EPS (USD) (12/2014) -0.5770
Est. PEG Ratio -
Market Cap (M USD) 393.16
Shares Outstanding (M) 21.92
30 Day Average Volume 312,198
Price/Book (mrq) 2.0488
Price/Sale (ttm) 4.6485
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 07/29/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for AMAG

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for AMAG

AMAG Pharmaceuticals, Inc., a biopharmaceutical company, utilizes its proprietary nanoparticle technology for the development and commercialization of therapeutic iron compounds to treat anemia and novel imaging agents to aid in the diagnosis of cancer and cardiovascular disease.

William K HeidenPresident/CEOScott A HolmesCAO/Senior VP:Finance
Frank E ThomasExec VP/COOScott B TownsendSenior VP:Legal Affairs/Secy
More Company Profile & Key Executives for AMAG

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil